Wedbush Cuts Price Target on NuPathe (PATH) Following Complete Response Letter From FDA

Go back to Wedbush Cuts Price Target on NuPathe (PATH) Following Complete Response Letter From FDA
NUPATHE (NYSE: PATH) Delayed: 15.99 -0.02 (0.12%)
Previous Close $16.01    52 Week High $4.49 
Open $15.95    52 Week Low $1.57 
Day High $16.27    P/E N/A 
Day Low $15.63    EPS $-2.31 
Volume 72,188,139